GALT Polyclonal Antibody
Product Specifications
Background
GALT (Galactose 1 phosphate uridyl transferase) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP glucose + galactose 1 phosphate to glucose 1 phosphate + UDP galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined.
Synonyms
Gal 1 P uridylyltransferase; Galactose 1 phosphate uridyl transferase; Galactose 1 phosphate uridylyltransferase; UDP glucose hexose 1 phosphate uridylyltransferase; GALT_HUMAN.
Gene ID
2592
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Mouse, Rat
Immunogen
251-350/379
Target
GALT
Clonality
Polyclonal
Isotype
IgG
Conjugation
Unconjugated
Source
KLH conjugated synthetic peptide derived from human GALT
Applications
WB, ELISA, IHC-P, IHC-F, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Concentration
1µg/µl
Dilution
WB (1:300-5000), ELISA (1:500-1000), IHC-P (1:200-400), IHC-F (1:100-500), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Gene ID URL
2592
Predicted Cross Reactivity
Human, Cow
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2828655-01 1 mg
Anti-human CD59 (Quark patent Anti-CD59 Biosimilar)
Sign In for Pricing
View Details 
orb2828655-02 5 mg
Anti-human CD59 (Quark patent Anti-CD59 Biosimilar)
Sign In for Pricing
View Details 
orb2828655-03 20 mg
Anti-human CD59 (Quark patent Anti-CD59 Biosimilar)
Sign In for Pricing
View Details 